Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
International Urology and Nephrology
Erschienen in: International Urology and Nephrology 1/2012

01.02.2012 | Urology – Review

Advanced penile cancer

verfasst von: Jonathan E. Heinlen, David D. Buethe, Daniel Joseph Culkin

Erschienen in: International Urology and Nephrology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Penile cancer is an uncommon disease in the industrialized world that most frequently presents at low stage and is cured with treatment of local and regional surgery. In cases of advanced cancer, the use of more aggressive surgical techniques and the addition of adjuvant therapy may be warranted. So far, few agents have been found that improve survival with metastatic disease and thus aggressive primary treatment is required. This review discusses diagnosis, staging, and therapy for high risk penile cancer.
Literatur
1.
Pow-Sang MR et al (2010) Epidemiology and natural history of penile cancer. Urology 76(2 Suppl 1):S2–S6PubMedCrossRef
2.
Soria JC et al (1997) Squamous cell carcinoma of the penis: multivariate analysis of prognostic factors and natural history in a monocentric study with a conservative policy. Ann Oncol 8(11):1089–1098PubMedCrossRef
3.
Tseng HF et al (2001) Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (US). Cancer Causes Control 12(3):267–277CrossRef
4.
Maden C et al (1993) History of circumcision, medical conditions, and sexual-activity and risk of penile cancer. J Natl Cancer Inst 85(1):19–24PubMedCrossRef
5.
6.
Hungerhuber E et al (2006) Risk stratification in penile carcinoma: 25-year experience with surgical inguinal lymph node staging. Urology 68(3):621–625PubMedCrossRef
7.
Antunes AA, Dall’Oglio MF, Srougi M (2007) Organ-sparing treatment for penile cancer. Nat Clin Pract Urol 4(11):596–604PubMedCrossRef
8.
Hardner GJ et al (1972) Carcinoma of the penis: analysis of therapy in 100 consecutive cases. J Urol 108(3):428–430PubMed
9.
Lont AP et al (2007) Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival. J Urol 177(3):947–952PubMedCrossRef
10.
11.
Haas GP et al (1999) Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a southwest oncology group study. J Urol 161(6):1823–1825PubMedCrossRef
12.
Srinivas V et al (1987) Penile cancer: relation of extent of nodal metastasis to survival. J Urol 137(5):880–882PubMed
13.
Ravi R (1993) Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis. Br J Urol 72(5 Pt 2):817–819PubMedCrossRef
14.
Ornellas AA et al (1994) Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases. J Urol 151(5):1244–1249PubMed
15.
Scardino E et al (2004) Magnetic resonance imaging combined with artificial erection for local staging of penile cancer. Urology 63(6):1158–1162PubMedCrossRef
16.
Hughes B et al (2009) Non-invasive and minimally invasive staging of regional lymph nodes in penile cancer. World J Urol 27(2):197–203PubMedCrossRef
17.
Scher B et al (2005) 18F-FDG PET/CT for staging of penile cancer. J Nucl Med 46(9):1460–1465PubMed
18.
Schlenker B et al (2009) Detection of inguinal lymph node involvement in penile squamous cell carcinoma by 18F-fluorodeoxyglucose PET/CT: a prospective single-center study. Urol Oncol 30(9):753–769
19.
Graafland NM et al (2010) 18F-FDG PET/CT for monitoring induction chemotherapy in patients with primary inoperable penile carcinoma: first clinical results. Eur J Nucl Med Mol Imaging 37(8):1474–1480PubMedCrossRef
20.
21.
Tabatabaei S, Harisinghani M, McDougal WS (2005) Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer. J Urol 174(3):923–927 discussion 927PubMedCrossRef
22.
D’Ancona CA et al (1997) Quality of life after partial penectomy for penile carcinoma. Urology 50(4):593–596PubMedCrossRef
23.
Horenblas S, van Tinteren H (1994) Squamous cell carcinoma of the penis. IV. Prognostic factors of survival: analysis of tumor, nodes and metastasis classification system. J Urol 151(5):1239–1243PubMed
24.
Davis JW, Schellhammer PF, Schlossberg SM (1999) Conservative surgical therapy for penile and urethral carcinoma. Urology 53(2):386–392PubMedCrossRef
25.
Solsona E et al (2001) Prospective validation of association of local tumor stage and grade as predictive factor for occult lymph node micrometastases in patients with penile carcinoma and clinically negative inguinal lymph nodes. J Urol 165(5):1506–1509PubMedCrossRef
26.
Hegarty PK et al (2006) A prospective study of 100 cases of penile cancer managed according to European association of urology guidelines. BJU Int 98(3):526–531PubMedCrossRef
27.
Thuret R et al (2010) A contemporary population-based assessment of the rate of lymph node dissection for penile carcinoma. Ann Surg Oncol 18(2):439–446PubMedCrossRef
28.
Cabanas RM (1992) Anatomy and biopsy of sentinel lymph nodes. Urol Clin North Am 19(2):267–276PubMed
29.
Pettaway CA et al (1995) Sentinel lymph-node dissection for penile carcinoma: the M-D-Anderson-cancer-center experience. J Urol 154(6):1999–2003PubMedCrossRef
30.
Tanis PJ et al (2002) Dynamic sentinel node biopsy for penile cancer: reliability of a staging technique. J Urol 168(1):76–80PubMedCrossRef
31.
Spiess PE, Hernandez MS, Pettaway CA (2009) Contemporary inguinal lymph node dissection: minimizing complications. World J Urol 27(2):205–212PubMedCrossRef
32.
Hughes BE et al (2010) Lymph node metastasis in intermediate-risk penile squamous cell cancer: a two-centre experience. Eur Urol 57(4):688–692PubMedCrossRef
33.
Sanchez-Ortiz RF, Pettaway CA (2004) The role of lymphadenectomy in penile cancer. Urol Oncol 22(3):236–244 discussion 244–245PubMedCrossRef
34.
Daseler EH, Anson BJ, Reimann AF (1948) Radical excision of the inguinal and iliac lymph glands: a study based upon 450 anatomical dissections and upon supportive clinical observations. Surg Gynecol Obstet 87(6):679–694PubMed
35.
Evriviades D, Raurell A, Perks AG (2007) Pedicled anterolateral thigh flap for reconstruction after radical groin dissection. Urology 70(5):996–999PubMedCrossRef
36.
Bermejo C et al (2007) Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol 177(4):1335–1338PubMedCrossRef
37.
Assimos DG, Jarow JP (1994) Role of laparoscopic pelvic lymph node dissection in the management of patients with penile cancer and inguinal adenopathy. J Endourol 8(5):365–369PubMedCrossRef
38.
Mahlmann B, Doehn C, Feyerabend T (2001) Radiotherapy of penile cancer. Urol A 40(4):308CrossRef
39.
de Crevoisier R et al (2009) Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N− or NX). Int J Radiat Oncol Biol Phys 74(4):1150–1156PubMedCrossRef
40.
Crook J, Ma C, Grimard L (2009) Radiation therapy in the management of the primary penile tumor: an update. World J Urol 27(2):189–196PubMedCrossRef
41.
Crook J, Jezioranski J, Cygler JE (2010) Penile brachytherapy: technical aspects and post implant issues. Brachytherapy 9(2):151–158PubMedCrossRef
42.
Crook JM et al (2005) Penile brachytherapy: results for 49 patients. Int J Radiat Oncol Biol Phys 62(2):460–467PubMedCrossRef
43.
Murrell DS, Williams JL (1965) Radiotherapy in the treatment of carcinoma of the penis. Br J Urol 37:211–222PubMedCrossRef
44.
Edsmyr F, Andersson L, Esposti PL (1985) Combined bleomycin and radiation therapy in carcinoma of the penis. Cancer 56(6):1257–1263PubMedCrossRef
45.
Ahmed T, Sklaroff R, Yagoda A (1984) An appraisal of the efficacy of bleomycin in epidermoid carcinoma of the penis. Anticancer Res 4(4–5):289–292PubMed
46.
Ahmed T, Sklaroff R, Yagoda A (1984) Sequential trials of methotrexate, cisplatin and bleomycin for penile cancer. J Urol 132(3):465–468PubMed
47.
Hussein AM, Benedetto P, Sridhar KS (1990) Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas. Cancer 65(3):433–438PubMedCrossRef
48.
Dexeus FH et al (1991) Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract. J Urol 146(5):1284–1287PubMed
49.
Hakenberg OW et al (2006) Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma. BJU Int 98(6):1225–1227PubMedCrossRef
50.
Pizzocaro G, Piva L (1998) Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol 27(6b):823–824
51.
Theodore C et al (2008) A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992). Ann Oncol 19(7):1304–1307PubMedCrossRef
52.
Pagliaro LC et al (2010) Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol 28(24):3851–3857PubMedCrossRef
53.
Modig H, Duchek M, Sjodin JG (1993) Carcinoma of the penis. Treatment by surgery or combined bleomycin and radiation therapy. Acta Oncol 32(6):653–655PubMedCrossRef
54.
Gotsadze D et al (2000) Is conservative organ-sparing treatment of penile carcinoma justified? Eur Urol 38(3):306–312PubMedCrossRef
55.
Perez-Tamayot C (1987) Combined approach to squamous cell carcinoma of the penis (SCP). Proc Am Soc Clin Oncol 6:109
56.
Clavel M et al (1994) Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC head and neck cancer cooperative group. Ann Oncol 5(6):521–526PubMed
57.
Leijte JA et al (2007) Neoadjuvant chemotherapy in advanced penile carcinoma. Eur Urol 52(2):488–494PubMedCrossRef
58.
Edge SB, Byrd DR, Compton CC et al (eds) (2010) AJCC cancer staging manual, 7th edn. Springer, NY, p 449
Metadaten
Titel
Advanced penile cancer
verfasst von
Jonathan E. Heinlen
David D. Buethe
Daniel Joseph Culkin
Publikationsdatum
01.02.2012
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 1/2012
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-011-0011-1

Weitere Artikel der Ausgabe 1/2012

International Urology and Nephrology 1/2012 Zur Ausgabe

Urology – Original Paper

Predictors for spontaneous stone passage in patients with renal colic secondary to ureteral calculi

Urology – Review

Complex renal cystic masses: current standards and controversies

Nephrology – Original Paper

Clinical usefulness of lanthanum carbonate for serum phosphate control in difficult patients

Urology – Review

Importance of hypogonadism and testosterone replacement therapy in current urologic practice: a review

Nephrology – Original Paper

Hemodialysis duration impairs food intake and nutritional parameters in chronic kidney disease patients

Urology – Case Report

Metastatic Crohn’s disease of the penis: two cases

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise